Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
QuintilesIMS
Express Scripts
Cipla
Argus Health
Deloitte

Generated: September 18, 2019

DrugPatentWatch Database Preview

Litigation Details for Sanofi-Aventis v. Wockhardt Limited (D. Del. 2008)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Sanofi-Aventis v. Wockhardt Limited (D. Del. 2008)

Docket   Try a Free Trial Date Filed 2008-03-14
Court District Court, D. Delaware Date Terminated 2010-08-03
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties SANOFI-AVENTIS; SANOFI-AVENTIS US LLC; WOCKHARDT LIMITED; WOCKHARDT USA INC.
Patents 4,661,491; 4,839,177; 5,422,123; 6,149,940
Attorneys Gerald J. Flattmann , Jr.; Jack B. Blumenfeld; James Walter Parrett , Jr.; Kelly E. Farnan
Firms Deep Ellum Search; Morris, Nichols, Arsht & Tunnell; Richards, Layton & Finger, PA
Link to Docket External link to docket
Small Molecule Drugs cited in Sanofi-Aventis v. Wockhardt Limited
The small molecule drugs covered by the patents cited in this case are   Try a Free Trial ,   Try a Free Trial ,   Try a Free Trial ,   Try a Free Trial ,   Try a Free Trial , and   Try a Free Trial .

Details for Sanofi-Aventis v. Wockhardt Limited (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-03-14 1 Complaint 474, 455 [56] Rcferences Cited U.S. PATENT DOCUMENTS 4,661,491 4/1987 Regnier ....................…States Patent No. 6,149,940 (“the ‘940 patent”) (Exhibit A). This action is based upon the Patent Laws …United Stat€S Patent [19] [11] Patent Number: 6,149,940 Maggi et al. [45] Date of Patent: Nov. 21, 2000…1391 and l400(b). The ‘940 Patent ll. On Novernber 21, 2000, the ‘940 patent, titled “Tablet with Controlled… infringement of the ‘940 patent, prior to the expiration of the ‘940 patent, including any extensions External link to document
2008-03-14 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,149,940; (els) (Entered: 03… OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 6,149,940 …Wockhardt USA, Inc. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
2008-05-07 9 Answer to Complaint States patent laws, 35 U.SC §l et seq for infringement of United States Patent Nc. 6,149,940 (“the ‘940…proposed ANDA product 32. United States Patent l\lo. 6,149,940 is entitied “Tablet With Controlied Reiease…entered declaring all claims of United States Patent No. 6,149,940 invalid; (4) That Woel<hardt has a lawful…Writing with infringement of United States Patent' No. 6,149,940; (6) That ajudgment be entered declaring… action onin The ‘940 Patent t t t Woci<harcit admits that the ‘940 patent is entitled “*i"abiet External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Fish and Richardson
Mallinckrodt
Baxter
Accenture
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.